Abstract
No acute ocular atropinic effect of nebulized ipratropium bromide administered by carefully applied or deliberately misplaced face-mask has been demonstrated.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Accommodation, Ocular / drug effects*
-
Adolescent
-
Adult
-
Aerosols
-
Atropine Derivatives / administration & dosage*
-
Double-Blind Method
-
Female
-
Humans
-
Ipratropium / administration & dosage*
-
Ipratropium / toxicity
-
Male
-
Masks
-
Pupil / drug effects*
-
Random Allocation
-
Respiratory Therapy
Substances
-
Aerosols
-
Atropine Derivatives
-
Ipratropium